India is rapidly shifting from being viewed simply as an affordable destination for treatment to becoming a genuine global medical tourism hub, with foreign patient volumes and market size both climbing sharply over the past decade and a half.
The numbers
Foreign patient arrivals for treatment in India rose from 112,000 in 2009 to 507,000 in 2025, a nearly 4.5-fold increase over 16 years. A large share of these patients came from Bangladesh, Iraq, Uzbekistan, Somalia, Oman, and Kenya, pointing to India’s growing pull not just among price-sensitive neighbouring markets but also across the Middle East and East Africa.
The market itself reflects this growth: valued at ₹84,000 crore in 2025, India’s medical tourism sector is projected to nearly double to ₹1.56 lakh crore by 2030.
What’s driving the growth
Cost has traditionally been cited as India’s core advantage, and the gap remains striking, a treatment costing ₹15,000 in the United States can often be done in India for ₹1,000–2,000, while routine dental treatment priced ₹16,000 higher in the Netherlands can be completed in Lucknow for around ₹3,000. But industry observers say cost alone no longer explains the surge. Three additional factors stand out: fast access to specialist doctors, quick diagnostic turnaround, and transparent, pre-determined treatment costs that let foreign patients plan with confidence rather than face open-ended billing uncertainty, a pain point common in many Western healthcare systems.
The infrastructure underpinning this is substantial. India has 69,364 hospitals, of which 43,486 (about 66%) are private, alongside 25,778 government hospitals. The country has 1.2 million registered doctors, and 1,299 hospitals hold accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) — a credential that matters heavily to international patients evaluating quality and safety before travelling abroad for care.
Policy has also played an enabling role. India now offers e-Medical Visas to citizens of 172 countries, alongside e-Medical Attendant Visas for accompanying caregivers, and a dedicated e-Ayush Visa category for those seeking treatment through traditional Indian systems of medicine such as Ayurveda, Yoga, Unani, and Homoeopathy. The government-backed Heal in India portal is also being developed into a unified platform to help international patients navigate hospital choice, doctor credentials, and treatment planning.
Implications and impact
For India’s healthcare sector, sustained growth in medical tourism represents a meaningful new revenue stream that could help private hospital chains improve capacity utilisation and fund further investment in specialist equipment and accreditation, potentially raising care standards for domestic patients as a byproduct. It also has broader economic implications: medical tourism brings foreign exchange earnings, supports allied sectors such as hospitality, medical interpretation services, and air travel, and can help build India’s soft-power positioning as a trusted global healthcare provider rather than purely a low-cost back office for the world.
There are real strains to watch, however. A near-doubling of the market by 2030 will test capacity in exactly the specialist departments, neurology, cardiology, oncology, orthopaedics, that are already in high demand domestically. If foreign patient inflows are not managed carefully, there is a risk of perceived or real crowding-out effects on wait times for local patients, an issue that has surfaced in other medical tourism hubs globally. How hospitals and policymakers balance international patient revenue against domestic access will likely shape public perception of the sector’s growth.
The competitive dynamic is also notable. India is explicitly drawing patients who previously travelled to Türkiye and Thailand, two established medical tourism hubs, citing access to specialist doctors, internationally accredited hospitals, and lower costs as the deciding factors. This suggests India is no longer simply carving out a niche but is competing directly for a global patient base against countries with longer track records in medical tourism branding and infrastructure.
Potential
If current trends hold, India’s traction with patients from the Middle East, East Africa, and South Asia could deepen further as digital platforms make it easier for prospective patients to research doctors and hospitals before booking travel, reducing the information asymmetry that has historically made medical travel feel risky. The anecdote of a British patient who received a next-day neurology consultation, with MRI and blood test results within an hour, after facing a year-long wait at home, illustrates the core value proposition India is now marketing globally: speed and certainty of care, not just its price.
Over the next five years, India’s ability to scale accreditation (NABH-certified hospitals remain a small fraction of the total 69,000-plus hospital base), maintain quality consistency across private and government facilities, and expand visa and digital infrastructure will likely determine whether the sector reaches its projected ₹1.56 lakh crore valuation, or whether capacity and quality bottlenecks slow the pace of growth before then.
MB Bureau
Centre opens applications for medical device cluster infrastructure to cut imports
US hospitals accelerating RCM outsourcing to India
